3D Bioprinting Market Size Analysis, Growth and Trends By Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting), Material (Living Cells, Hydrogels, Extracellular Matrices), Application (Research Applications, Clinical Applications), Key Players and Region, Forecast to 2023
3D Bioprinting Market Trends Analysis
The global 3D Bioprinting Market size and share is projected to reach USD 1,923.02 million at a 24.59% CAGR by 2023, reveals the latest Market Research Future (MRFR) report. 3D bioprinting is a branch of 3D printing that prints three-dimensional organs and tissues from bio inks that are specially formulated. Bio inks are made from a mixture of living cells, stem-cells, or chemicals. It has a wide range of applications, including cancer research, high-throughput assays, drug screening, transplantation and clinics, regenerative medicine, and tissue engineering.
3D bioprinting market is expected to propel growth based on growing geriatric population, increased research and development investments, technological advancements, growing compliance in drug development and discovery, a limited number of organ donors, and increasing cases of chronic diseases. 3D bioprinting market is projected to go rapidly owing to growing use of 3D bioprinting in cosmetic surgeries, innovations in 3D bioprinting technologies and pharmaceutical industries, increasing grants, funds, and investments for research by public-private organizations and an increasing number of organ transplantation.
On the flip side, the scarcity of skilled professionals for operating 3D bioprinting technologies that are technologically advanced may hamper the 3D bioprinting market growth over the forecast period.
Request Free Sample Report: https://www.marketresearchfuture.com/sample_request/869
3D Bioprinting Market Segmentation:
3D bioprinting market is segmented by application, material, end users and technology.
By technology, the 3D bioprinting market is segmented into magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, and microextrusion bioprinting. Of these, the microextrusion bioprinting segment will have the largest share in the market over the forecast period owing to its wide applications in bioprinting.
By material, the 3D bioprinting market is segmented into extracellular matrices, hydrogels, and living cells. Of these, the living cells segment will dominate the market over the forecast period owing to the accelerated production process of micro building blocks.
By applications, the 3D bioprinting market is segmented into clinical applications and research applications. Of these, the research applications segment will lead the market over the forecast period due to its wide applications in regenerative medicine and 3D cell culture.
By end user, the 3D bioprinting market is segmented into research organizations and academic institutes and pharmaceutical and biotechnology companies. Of these, the pharmaceutical and biotechnology institutes will have the maximum share in the market over the forecast period due to the growing trend in personalized medicines.
3D Bioprinting Market Regional Analysis
By region, the 3D bioprinting market is segmented into Asia Pacific, the Americas, the Middle East, and Africa, and Europe. Of these, the Americas will lead the market over the forecast period. This is chiefly on account of the growing demand for organs among the patient pool, the presence of developed healthcare infrastructure, and increasing investments in R&D activities. Moreover, the availability of 3D printed pills that can be customized as per the body weight and age of a person is also boosting the market growth.
The global 3D bioprinting market in the APAC region is expected to grow at the fastest pace during the forecast period. This is chiefly on account of plenty of opportunities, developments in 3D printing, booming healthcare sector, and government funds for accelerating the 3D printing technology pace.
The global 3D bioprinting market in Europe is expected to have a healthy growth over the forecast period owing to the growing focus on health and wellness, increasing demand for cosmetic surgery, and agreements amongst key players for expediting the evolution of technology.
The 3D bioprinting market in the MEA is predicted to have a stable growth over the forecast period.
3D Bioprinting Market Key Players
Major players profiled in the 3D bioprinting market report include Cyfuse Biomedical K.K. (Japan), EnvisionTEC GmbH (Germany), Cellink AB (Sweden), Poietis (France), Stratasys Ltd. (US), Aspect Biosystems Ltd. (Canada), Regenovo Biotechnology Co. Ltd. (China), Organovo Holdings Inc. (US), Allevi (US), FUJIFILM Wako Automation Corporation (US), REGENHU Ltd. (Switzerland), and Nano3D Biosciences Inc. (US).
Industry News
Researchers at the University of Birmingham, UK has recently created a new 3D bioprinting technique using soft materials such as collagen and gels.
Browse Complete Research Report at: https://www.marketresearchfuture.com/reports/3d-bioprinting-market-869
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
